The medicine is called Evusheld, and its effectiveness is waning dramatically because new Covid-19 subvariants are taking center stage, and the drug doesn’t neutralize all of them.
The first hypothesis suggests people’s immune systems are weaker now, due to a lack of exposure to viruses while observing COVID-19 public health measures over the last two-and-a-half years.
Recent Comments